Skip to main content

What the FDA labels say about taking them together

Fluvoxamine and ropivacaine

Ropivacaine's FDA label of August 6, 2024 names fluvoxamine in its drug interactions section; the fluvoxamine labels PlainMeds reads (2) do not name ropivacaine. The ropivacaine label: “In vivo, the plasma clearance of ropivacaine was reduced by 70% during coadministration of fluvoxamine (25 mg bid for 2 days), a selective and potent CYP1A2 inhibitor.”

Check it at the source: the fluvoxamine FDA label on DailyMed (effective June 27, 2026, Zydus Pharmaceuticals USA Inc.); the ropivacaine FDA label on DailyMed (effective August 6, 2024, Fresenius Kabi USA, LLC).

What does the fluvoxamine label say about ropivacaine?

Fluvoxamine's label (effective June 27, 2026) and its 1 other brand-application label do not name ropivacaine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Fluvoxamine maleate extended-release), Zydus Pharmaceuticals USA Inc., effective June 27, 2026 (SPL set 6c71d4f6-54b5-4d3a-8d2f-b7773c92c32e), via openFDA; the full label on DailyMed

What does the ropivacaine label say about fluvoxamine?

Ropivacaine label, drug interactions

In vivo, the plasma clearance of ropivacaine was reduced by 70% during coadministration of fluvoxamine (25 mg bid for 2 days), a selective and potent CYP1A2 inhibitor.

Source: FDA drug label (Naropin), Fresenius Kabi USA, LLC, effective August 6, 2024 (SPL set 23d2d448-a744-4877-9f2d-7e57c198da89), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

16Fluvoxamine generic labelers
18Ropivacaine generic labelers
FluvoxamineRopivacaine
Labeled forn/aPain
Boxed warningYesNo
Pharmacy cost (NADAC)$4.08 per capsule 100 mg capsulen/a
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?